Sökning: WFRF:(Kumar G Anil) > (2009) > VEGF-B is dispensab...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 06305naa a2200721 4500 | |
001 | oai:DiVA.org:uu-105750 | |
003 | SwePub | |
008 | 090608s2009 | |||||||||||000 ||eng| | |
009 | oai:prod.swepub.kib.ki.se:118626170 | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-1057502 URI |
024 | 7 | a https://doi.org/10.1073/pnas.08130611062 DOI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1186261702 URI |
040 | a (SwePub)uud (SwePub)ki | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Zhang, Fanu National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA4 aut |
245 | 1 0 | a VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis |
264 | c 2009-04-14 | |
264 | 1 | b Proceedings of the National Academy of Sciences,c 2009 |
338 | a print2 rdacarrier | |
520 | a VEGF-B, a homolog of VEGF discovered a long time ago, has not been considered an important target in antiangiogenic therapy. Instead, it has received little attention from the field. In this study, using different animal models and multiple types of vascular cells, we revealed that although VEGF-B is dispensable for blood vessel growth, it is critical for their survival. Importantly, the survival effect of VEGF-B is not only on vascular endothelial cells, but also on pericytes, smooth muscle cells, and vascular stem/progenitor cells. In vivo, VEGF-B targeting inhibited both choroidal and retinal neovascularization. Mechanistically, we found that the vascular survival effect of VEGF-B is achieved by regulating the expression of many vascular prosurvival genes via both NP-1 and VEGFR-1. Our work thus indicates that the function of VEGF-B in the vascular system is to act as a "survival," rather than an "angiogenic" factor and that VEGF-B inhibition may offer new therapeutic opportunities to treat neovascular diseases. | |
653 | a Apoptosis | |
653 | a vascular survival | |
653 | a ocular neovascularization | |
653 | a MEDICINE | |
653 | a MEDICIN | |
700 | 1 | a Tang, Zhongshuu National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA4 aut |
700 | 1 | a Hou, Xuu National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA4 aut |
700 | 1 | a Lennartsson, Johanu Uppsala universitet,Ludwiginstitutet för cancerforskning4 aut0 (Swepub:uu)johalenn |
700 | 1 | a Li, Yangu National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA4 aut |
700 | 1 | a Koch, Alexander W.u Neurodegeneration Labs, Protein Chemistry, Genentech, Inc. San Francisco, CA 94080, USA4 aut |
700 | 1 | a Scotney, Pierreu CSL Limited, Parkville, Victoria 3052, Australia4 aut |
700 | 1 | a Lee, Chunsiku National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA4 aut |
700 | 1 | a Arjunan, Pachiappanu National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA4 aut |
700 | 1 | a Dong, Lijinu National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA4 aut |
700 | 1 | a Kumar, Anilu National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA4 aut |
700 | 1 | a Rissanen, Tuomas T.u Department of Biotechnology and Molecular Medicine, University of Kuopio, FIN-70211, Kuopio, Finland4 aut |
700 | 1 | a Wang, Binu Department of Radiology, Medical Imaging Centre of the Affiliated Hospital, Weifang Medical University, Weifang 261042, China4 aut |
700 | 1 | a Nagai, Nobuou Department of Physiology, Kinki University School of Medicine, Osaka 589-8511, Japan4 aut |
700 | 1 | a Fons, Pierreu Sanofi-Aventis Recherche, Cardiovascular-Thrombosis Research Department, 31036 Toulouse Cedex, France4 aut |
700 | 1 | a Fariss, Robertu National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA4 aut |
700 | 1 | a Zhang, Yongqingu TRIAD Technology Center, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA4 aut |
700 | 1 | a Wawrousek, Ericu National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA4 aut |
700 | 1 | a Tansey, Gingeru National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA4 aut |
700 | 1 | a Raber, Jamesu National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA4 aut |
700 | 1 | a Fong, Guo-Huau Center for Vascular Biology, University of Connecticut, Farmington, CT 06030, USA4 aut |
700 | 1 | a Ding, Haou Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, Canada MB R3E 3P54 aut |
700 | 1 | a Greenberg, David A.u Buck Institute for Age Research, Novato, CA 94945, USA4 aut |
700 | 1 | a Becker, Kevin G.u TRIAD Technology Center, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA4 aut |
700 | 1 | a Herbert, Jean-Marcu Sanofi-Aventis Recherche, Cardiovascular-Thrombosis Research Department, 31036 Toulouse Cedex, France4 aut |
700 | 1 | a Nash, Andrewu CSL Limited, Parkville, Victoria 3052, Australia4 aut |
700 | 1 | a Yla-Herttuala, Seppou Department of Biotechnology and Molecular Medicine, University of Kuopio, FIN-70211, Kuopio, Finland4 aut |
700 | 1 | a Cao, Yihaiu Karolinska Institutet4 aut |
700 | 1 | a Watts, Ryan J.u Neurodegeneration Labs, Protein Chemistry, Genentech, Inc. San Francisco, CA 94080; dCSL Limited, Parkville, Victoria 3052, Australia4 aut |
700 | 1 | a Li, Xuriu National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA4 aut |
710 | 2 | a National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USAb Ludwiginstitutet för cancerforskning4 org |
773 | 0 | t Proceedings of the National Academy of Sciences of the United States of Americad : Proceedings of the National Academy of Sciencesg 106:15, s. 6152-6157q 106:15<6152-6157x 0027-8424x 1091-6490 |
856 | 4 | u https://www.pnas.org/content/pnas/106/15/6152.full.pdf |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-105750 |
856 | 4 8 | u https://doi.org/10.1073/pnas.0813061106 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:118626170 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy